Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Alibaba Health Information Technology ( (HK:0241) ) has provided an update.
Alibaba Health Information Technology Limited has announced an upcoming board meeting scheduled for November 26, 2025, to discuss and approve the unaudited interim results for the six months ending September 30, 2025. The meeting will also consider the recommendation of an interim dividend, which could impact the company’s financial strategy and shareholder returns.
The most recent analyst rating on (HK:0241) stock is a Hold with a HK$6.50 price target. To see the full list of analyst forecasts on Alibaba Health Information Technology stock, see the HK:0241 Stock Forecast page.
More about Alibaba Health Information Technology
Alibaba Health Information Technology Limited operates in the healthcare industry, focusing on providing digital health services and products. The company leverages technology to enhance healthcare delivery and is part of the larger Alibaba Group ecosystem, aiming to integrate healthcare resources and improve service accessibility.
Average Trading Volume: 126,108,771
Technical Sentiment Signal: Buy
Current Market Cap: HK$94.46B
See more insights into 0241 stock on TipRanks’ Stock Analysis page.